IP Library › Granted Patent US 12,527,941
Granted Patent B2
US 12,527,941 · App. 17/884,402 · Granted Jan 20, 2026

Introducer components, assemblies, and methods thereof

Inventor: Glade H. Howell (Draper, UT)
Assignee: Bard Access Systems, Inc.
A61M25/09041A61M5/3287A61M5/3293
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,527,941
App. No.
17/884,402
Granted
Jan 20, 2026
Kind
B2
Abstract

Disclosed are introducer components, assemblies, and methods. For example, an introducer assembly can include a syringe and a needle assembly fluidly connected thereto. The needle assembly can include a needle and an access guidewire-advancement mechanism mounted on a proximal linear portion of a needle shaft of the needle. The needle shaft can include a sigmoid portion between a distal linear portion of the needle shaft and the proximal linear portion as well as a port in a transition from the sigmoid portion to the distal linear portion of the needle shaft. An access guidewire can be loaded in both the access guidewire-advancement mechanism and a needle-shaft lumen in the distal linear portion of the needle shaft in a ready-to-deploy state of the introducer assembly. In this way, the access guidewire can be immediately advanced into a blood-vessel lumen upon establishing a needle tract thereto with the needle.

Claims (45)

1 . An introducer assembly, comprising:

a syringe;

a needle assembly fluidly connected to the syringe, the needle assembly including:

a needle including:

a needle shaft including:

a sigmoid portion between a distal linear portion and a proximal linear portion; and

a port in a transition from the sigmoid portion of the needle shaft to the distal linear portion of the needle shaft; and

a needle hub over the proximal linear portion of the needle shaft; and

an access guidewire-advancement mechanism mounted on the proximal linear portion of the needle shaft distal of the needle hub; and

an access guidewire loaded in both the access guidewire-advancement mechanism and a needle-shaft lumen in the distal linear portion of the needle shaft in a ready-to-deploy state of the introducer assembly.

2 . The introducer assembly of claim 1 , wherein the access guidewire extends along a barrel wall of the syringe, through the access guidewire-advancement mechanism, through the port in the needle shaft, and into the needle-shaft lumen in the distal linear portion of the needle shaft without appreciably bending, a distal end of the access guidewire disposed just proximal of a needle tip in the distal linear portion of the needle shaft in the ready-to-deploy state of the introducer assembly.

3 . The introducer assembly of claim 1 , wherein the access guidewire includes a ‘J’-shaped guidewire tip that assumes a straightened state in the ready-to-deploy state of the introducer assembly and a curved state when the ‘J’-shaped guidewire tip is advanced beyond a distal end of the needle shaft in a deployed state of the introducer assembly.

4 . The introducer assembly of claim 1 , wherein the access guidewire includes a bare-wire portion and a wound-wire portion proximal of the bare-wire portion, the bare-wire portion distally extending through the port in at least the ready-to-deploy state of the introducer assembly.

5 . The introducer assembly of claim 1 , wherein the access guidewire includes a proximal portion proximally extending from the access guidewire-advancement mechanism in the ready-to-deploy state of the introducer assembly, the proximal portion of the access guidewire disposed in a sterile barrier configured to maintain sterility of the access guidewire.

6 . The introducer assembly of claim 1 , wherein the port includes a valve configured to form a fluid-tight seal around the access guidewire.

7 . The introducer assembly of claim 6 , wherein the valve includes a split septum compressed in the port.

8 . The introducer assembly of claim 1 , wherein the access guidewire-advancement mechanism includes a thumbwheel device configured to advance the access guidewire when the access guidewire is pressed into a thumbwheel and the thumbwheel is rotated.

9 . The introducer assembly of claim 1 , wherein the needle hub further includes a needle-hub connector including a needle-hub bore in a proximal portion of the needle hub, a syringe tip of the syringe disposed in the needle-hub bore, thereby fluidly connecting the needle to the syringe.

10 . A needle assembly, comprising:

a needle including:

a needle shaft including:

a sigmoid portion between a distal linear portion and a proximal linear portion; and

a port in a transition from the sigmoid portion of the needle shaft to the distal linear portion of the needle shaft, wherein the port includes a valve configured to form a fluid-tight seal around an access guidewire; and

a needle hub over the proximal linear portion of the needle shaft.

11 . The needle assembly of claim 10 , further comprising an access guidewire-advancement mechanism over the proximal linear portion of the needle shaft distal of the needle hub.

12 . The needle assembly of claim 10 , wherein the valve includes a split septum compressed in the port.

13 . The needle assembly of claim 11 , wherein the access guidewire-advancement mechanism includes a thumbwheel device configured to advance the access guidewire when the access guidewire is pressed into a thumbwheel and the thumbwheel is rotated.

14 . A method for securing vascular access, comprising:

obtaining an introducer assembly, the introducer assembly including:

a syringe; and

a needle assembly fluidly connected to the syringe, the needle assembly including:

a needle having a sigmoid portion between a distal linear portion and a proximal linear portion with a port in a transition from the sigmoid portion of a needle shaft to the distal linear portion of the needle shaft; and

an access guidewire-advancement mechanism mounted on the proximal linear portion of the needle shaft, distal of a needle hub for advancing an access guidewire into a blood-vessel lumen of a patient;

establishing a needle tract from an area of skin to the blood-vessel lumen with the needle; and

advancing at least a guidewire tip of the access guidewire into the blood-vessel lumen for securing the vascular access.

15 . The method of claim 14 , further comprising adjusting the introducer assembly such that the introducer assembly is in a ready-to-deploy state thereof with the guidewire tip of the access guidewire disposed just proximal of a needle tip in the distal linear portion of the needle shaft for advancing the access guidewire into the blood-vessel lumen immediately upon establishing the needle tract.

16 . The method of claim 15 , wherein the access guidewire extends along a barrel wall of the syringe, through the access guidewire-advancement mechanism, through the port in the needle shaft, and into a needle-shaft lumen in the distal linear portion of the needle shaft without appreciably bending in the ready-to-deploy state of the introducer assembly.

17 . The method of claim 14 , wherein advancing the access guidewire into the blood-vessel lumen includes rotating a thumbwheel of the access guidewire-advancement mechanism while the access guidewire is pressed against the thumbwheel.

18 . The method of claim 14 , wherein advancing the access guidewire into the blood-vessel lumen allows the guidewire tip of the access guidewire to transition from a straightened state in the needle shaft to a curved state in the blood-vessel lumen.

19 . The method of claim 14 , further comprising withdrawing a plunger from a barrel of the syringe to create a slight vacuum before reaching the blood-vessel lumen, the slight vacuum ensuring blood flashes back into at least a syringe tip to confirm establishing the needle tract.

20 . The method of claim 14 , further comprising aspirating blood with the syringe to confirm establishing the needle tract, a valve disposed in the port configured to form a fluid-tight seal around a bare-wire portion of the access guidewire for maintaining a vacuum during aspirating of the blood with the syringe.

21 . The method of claim 14 , further comprising withdrawing the needle from the patient leaving the access guidewire in the blood-vessel lumen.

22 . The method of claim 21 , wherein withdrawing the needle includes holding the access guidewire in place at or near the area of skin including the needle tract while withdrawing the needle over a proximal portion of the access guidewire.

23 . The method of claim 21 , further comprising disconnecting the needle from the syringe before withdrawing the needle from the patient.

24 . The method of claim 21 , further comprising bleeding air into the port while withdrawing the needle from the patient by pushing the access guidewire to a side of the port, the bleeding of air into the port obviating disconnecting the needle from the syringe.

Continuity (2)
Provisional Application 63231112 · Aug 9, 2021
Related Publication 20230039733A1 · Feb 9, 2023
References Cited (155)
US 3076457A · Copen · 1963 [cited by applicant]
US 3359978A · Smith, Jr. · 1967 [cited by applicant]
US 4743265A · Whitehouse et al. · 1988 [cited by applicant]
US 4886507A · Patton et al. · 1989 [cited by applicant]
US 4935008A · Lewis, Jr. · 1990 [cited by applicant]
US 4994040A · Cameron et al. · 1991 [cited by applicant]
US 5290244A · Moonka · 1994 [cited by applicant]
US 5380290A · Makower et al. · 1995 [cited by applicant]
US 5735813A · Lewis · 1998 [cited by applicant]
US 5853391A · Bell · 1998 [cited by applicant]
US 5971957A · Luther et al. · 1999 [cited by applicant]
US 6019736A · Avellanet et al. · 2000 [cited by applicant]
US 6159195A · Ha et al. · 2000 [cited by applicant]
US 7172587B2 · Poole et al. · 2007 [cited by applicant]
US 7938820B2 · Webster · 2011 [cited by examiner]
US 8882713B1 · Call et al. · 2014 [cited by applicant]
US 20020072712A1 · Nool et al. · 2002 [cited by applicant]
US 20030205843A1 · Adams · 2003 [cited by applicant]
US 20040092879A1 · Kraus et al. · 2004 [cited by applicant]
US 20040236346A1 · Parker · 2004 [cited by applicant]
US 20050021124A1 · Cunniffe et al. · 2005 [cited by applicant]
US 20050043684A1 · Basta et al. · 2005 [cited by applicant]
US 20070276288A1 · Khaw · 2007 [cited by applicant]
US 20080009793A1 · Dabbs · 2008 [cited by applicant]
US 20080027380A1 · Wholey et al. · 2008 [cited by applicant]
US 20080091137A1 · Reavill · 2008 [cited by applicant]
US 20090187147A1 · Kurth et al. · 2009 [cited by applicant]
US 20110071502A1 · Asai · 2011 [cited by applicant]
US 20130184659A1 · Byrnes et al. · 2013 [cited by applicant]
US 20150224287A1 · Bian et al. · 2015 [cited by applicant]
US 20150320968A1 · Konstantino et al. · 2015 [cited by applicant]
US 20160175563A1 · Woehr et al. · 2016 [cited by applicant]
US 20160220786A1 · Mitchell et al. · 2016 [cited by applicant]
US 20160310704A1 · Ng et al. · 2016 [cited by applicant]
US 20170035996A1 · O'Fallon · 2017 [cited by applicant]
US 20170258489A1 · Galili et al. · 2017 [cited by applicant]
US 20170296792A1 · Ornelas Vargas et al. · 2017 [cited by applicant]
US 20180043138A1 · Chu · 2018 [cited by applicant]
US 20190015637A1 · Jacobs · 2019 [cited by applicant]
US 20190022353A1 · Khanicheh et al. · 2019 [cited by applicant]
US 20190038113A1 · Chu · 2019 [cited by applicant]
US 20190134374A1 · Korkuch et al. · 2019 [cited by applicant]
US 20200008838A1 · Frey et al. · 2020 [cited by applicant]
US 20200107859A1 · Zhu · 2020 [cited by applicant]
US 20200147349A1 · Holt · 2020 [cited by applicant]
US 20200170559A1 · Burkholz et al. · 2020 [cited by applicant]
US 20200188650A1 · Al-Ali · 2020 [cited by applicant]
US 20200197682A1 · Franklin et al. · 2020 [cited by applicant]
US 20210085927A1 · Howell · 2021 [cited by applicant]
US 20210121661A1 · Howell · 2021 [cited by applicant]
US 20210330941A1 · Howell et al. · 2021 [cited by applicant]
US 20210332274A1 · Hoshi et al. · 2021 [cited by applicant]
US 20210361915A1 · Howell et al. · 2021 [cited by applicant]
US 20210402153A1 · Howell et al. · 2021 [cited by applicant]
US 20220362524A1 · Howell · 2022 [cited by applicant]
US 20220370762A1 · Blanchard et al. · 2022 [cited by applicant]
US 20230041261A1 · Howell · 2023 [cited by applicant]
US 20230043989A1 · Howell · 2023 [cited by applicant]
US 20230064542A1 · Howell · 2023 [cited by applicant]
US 20230086639A1 · Howell · 2023 [cited by applicant]
US 20230096377A1 · West et al. · 2023 [cited by applicant]
US 20230149667A1 · Lindekugel et al. · 2023 [cited by applicant]
US 20230181878A1 · Blanchard et al. · 2023 [cited by applicant]
US 20230201537A1 · Howell et al. · 2023 [cited by applicant]
US 20230201538A1 · Howell et al. · 2023 [cited by applicant]
US 20230218867A1 · Howell et al. · 2023 [cited by applicant]
US 20230381481A1 · Pizzato · 2023 [cited by applicant]
US 20240082549A1 · Spataro et al. · 2024 [cited by applicant]
US 20240226507A1 · Spataro · 2024 [cited by applicant]
CN 106422031B · 2021 [cited by applicant]
DE 4136051A1 · 1993 [cited by applicant]
DE 19750090A1 · 1999 [cited by applicant]
EP 0067260A1 · 1982 [cited by applicant]
EP 0155331A1 · 1985 [cited by applicant]
EP 0499147A2 · 1992 [cited by applicant]
EP 0641571A1 · 1995 [cited by applicant]
EP 1338299A1 · 2003 [cited by applicant]
EP 3193813A1 · 2017 [cited by applicant]
EP 3473291A1 · 2019 [cited by applicant]
JP H02255156A · 1990 [cited by applicant]
JP H077971Y2 · 1995 [cited by applicant]
JP 2004254879A · 2004 [cited by applicant]
JP 2009232917A · 2009 [cited by applicant]
JP 5101359B2 · 2012 [cited by applicant]
WO 8906986A1 · 1989 [cited by applicant]
WO 9509662A1 · 1995 [cited by applicant]
WO 9810821A1 · 1998 [cited by applicant]
WO 9959651A2 · 1999 [cited by applicant]
WO 02078776A2 · 2002 [cited by applicant]
WO 2005096778A2 · 2005 [cited by applicant]
WO 2009094089A1 · 2009 [cited by applicant]
WO 2011143621A1 · 2011 [cited by applicant]
WO 2012101089A1 · 2012 [cited by applicant]
WO 2013064215A1 · 2013 [cited by applicant]
WO 2015061172A1 · 2015 [cited by applicant]
WO 2016042544A1 · 2016 [cited by applicant]
WO 2016123278A1 · 2016 [cited by applicant]
WO 2016187063A1 · 2016 [cited by applicant]
WO 2020206280A2 · 2020 [cited by applicant]
WO 2021216902A1 · 2021 [cited by applicant]
WO 2021222116A2 · 2021 [cited by applicant]
WO 2022204049A1 · 2022 [cited by applicant]
WO 2022246271A2 · 2022 [cited by applicant]
WO 2022245774A3 · 2022 [cited by applicant]
WO 2023014994A1 · 2023 [cited by applicant]
WO 2023018669A1 · 2023 [cited by applicant]
WO 2023018729A1 · 2023 [cited by applicant]
WO 2023018733A1 · 2023 [cited by applicant]
WO 2023028138A2 · 2023 [cited by applicant]
WO 2023049174A1 · 2023 [cited by applicant]
WO 2023091586A1 · 2023 [cited by applicant]
WO 2023114324A1 · 2023 [cited by applicant]
WO 2023122312A1 · 2023 [cited by applicant]
WO 2023129457A1 · 2023 [cited by applicant]
WO 2023137077A1 · 2023 [cited by applicant]
WO 2024059073A1 · 2024 [cited by applicant]
WO 2024151869A1 · 2024 [cited by applicant]
PCT/US2022/029561 filed May 17, 2022 International Search Report and Written Opinion dated Nov. 9, 2022. [cited by applicant]
PCT/US2022/039742 filed Aug. 8, 2022 International Search Report and Written Opinion dated Dec. 21, 2022. [cited by applicant]
PCT/US2022/039852 filed Aug. 9, 2022 International Search Report and Written Opinion dated Dec. 6, 2022. [cited by applicant]
PCT/US2022/039861 filed Aug. 9, 2022, International Search Report and Written Opinion dated Jan. 5, 2023. [cited by applicant]
PCT/US2022/044242 filed Sep. 21, 2022 International Search Report and Written Opinion dated Feb. 8, 2023. [cited by applicant]
PCT/US2022/039742 filed Aug. 8, 2022 International Preliminary Report on Patentability dated Feb. 13, 2024. [cited by applicant]
PCT/US2022/041368 filed Aug. 24, 2022 International Preliminary Report on Patentability dated Feb. 27, 2024. [cited by applicant]
PCT/US2022/044242 filed Sep. 21, 2022 International Preliminary Report on Patentability dated Mar. 26, 2024. [cited by applicant]
PCT/US2022/053887 filed Dec. 22, 2022 International Search Report and Written Opinion dated May 8, 2023. [cited by applicant]
PCT/US2022/030365 filed May 20, 2022 International Search Report and Written Opinion dated Apr. 4, 2023. [cited by applicant]
PCT/US2022/041368 filed Aug. 24, 2022 International Search Report and Written Opinion dated Mar. 21, 2023. [cited by applicant]
PCT/US2022/050280 filed Nov. 17, 2022 International Search Report and Written Opinion dated Apr. 17, 2023. [cited by applicant]
PCT/US2022/052884 filed Dec. 14, 2022 International Search Report and Written Opinion dated May 15, 2023. [cited by applicant]
PCT/US2022/053724 filed Dec. 21, 2022 International Search Report and Written Opinion dated May 10, 2023. [cited by applicant]
PCT/US2023/010623 filed Jan. 11, 2023, International Search Report and Written Opinion dated Jul. 6, 2023. [cited by applicant]
PCT/US2022/021187 filed Mar. 21, 2022 International Search Report and Written Opinion dated Jun. 17, 2022. [cited by applicant]
PCT/US2023/032545 filed Sep. 12, 2023 International Search Report and Written Opinion dated Feb. 5, 2024. [cited by applicant]
U.S. Appl. No. 17/746,113, filed May 17, 2022 Restriction Requirement dated Dec. 11, 2024. [cited by applicant]
U.S. Appl. No. 17/700,152, filed Mar. 21, 2022 Restriction Requirement dated Jan. 31, 2025. [cited by applicant]
U.S. Appl. No. 17/746,113, filed May 17, 2022 Non-Final Office Action dated Apr. 7, 2025. [cited by applicant]
U.S. Appl. No. 17/750,097, filed May 20, 2022 Restriction Requirement dated Mar. 20, 2025. [cited by applicant]
U.S. Appl. No. 17/884,307, filed Aug. 9, 2022 Non-Final Office Action dated Apr. 2, 2025. [cited by applicant]
Adam et al. (Gastrointestinal Endoscopy vol. 77, No. 5S 2013, 1020) (Year: 2010). [cited by applicant]
Lapalu et al. “Totally implantable port management: impact of positive pressure during needle withdrawal on catheter tip occlusion (an experimental study)” The Journal of Vascular Access 2010; 11: 46-51, 2010 Wichtig Ed… [cited by applicant]
PCT/US2024/011269 filed Jan. 11, 2024 International Search Report and Written Opinion dated May 15, 2024. [cited by applicant]
U.S. Appl. No. 17/700,152, filed Mar. 21, 2022 Non-Final Office Action dated Aug. 14, 2025. [cited by applicant]
U.S. Appl. No. 17/700,152, filed Mar. 21, 2022 Restriction Requirement dated Apr. 29, 2025. [cited by applicant]
U.S. Appl. No. 17/750,097, filed May 20, 2022 Notice of Allowance dated Jun. 27, 2025. [cited by applicant]
U.S. Appl. No. 17/883,490, filed Aug. 8, 2022 Non-Final Office Action dated Jul. 31, 2025. [cited by applicant]
U.S. Appl. No. 17/894,759, filed Aug. 24, 2022 Non-Final Office Action dated Jun. 16, 2025. [cited by applicant]
U.S. Appl. No. 17/949,734, filed Sep. 21, 2022 Non-Final Office Action dated Aug. 4, 2025. [cited by applicant]
U.S. Appl. No. 18/081,491, filed Dec. 14, 2022 Non-Final Office Action dated Aug. 22, 2025. [cited by applicant]
PCT/US2025/032881 filed Jun. 9, 2025 International Search Report and Written Opinion dated Sep. 24, 2025. [cited by applicant]
U.S. Appl. No. 17/884,307, filed Aug. 9, 2022 Final Office Action dated Oct. 23, 2025. [cited by applicant]
U.S. Appl. No. 17/894,759, filed Aug. 24, 2022 Final Office Action dated Sep. 24, 2025. [cited by applicant]
U.S. Appl. No. 18/086,517, filed Dec. 21, 2022 Non-Final Office Action dated Oct. 31, 2025. [cited by applicant]
U.S. Appl. No. 18/087,676, filed Dec. 22, 2022 Restriction Requirement dated Oct. 8, 2025. [cited by applicant]
U.S. Appl. No. 18/095,968, filed Jan. 11, 2023 Restriction Requirement dated Nov. 24, 2025. [cited by applicant]